Switch to an antiretroviral treatment of expected lower potency after effective highly active antiretroviral therapy (HAART)

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):95-8. doi: 10.1097/00126334-200001010-00014.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Clinical Protocols
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors